knowledge -WSS

knowledge

author：fashion 2025-09-02 11:46:05 - browse：34

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Mass General, Mayo Clinic look to monetize custom

explore

hotspot

WSS

Clinical trials giant ICON acquires HumanFirst

How to fix the rural physician shortage in the U.S.

RaDonda Vaught to speak at CommonSpirit event on patient safety

Prior authorization reform is both possible and imperative

Obesity now affects over 1 billion people worldwide, study finds

FDA endorses new sterilization method for medical devices

entertainment

knowledge

entertainment

George Santos makes 1st court appearance after pleading not guilty to 13 counts

There's an unseen cost to disruptive road

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Maisha Meds is a PBM, but don't call it that

Dobbs anniversary: the lost opportunity of abortion as health care

Update the Apgar Score to remove skin color

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medicare bonuses could stop drug shortages under Senate plan

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medical device lobby: We're tired of waiting on Medicare coverage

leisure time

Medicare bonuses could stop drug shortages under Senate plan

FDA endorses new sterilization method for medical devices

Future doctors need a strong humanities education

Flu vaccine reformulation won't be easy, manufacturers warn

Inaction leaves children at risk from dangerous chemotherapy drug

Dana Farber says 6 studies to be retracted and 31 corrected

explore

explore

hotspot

leisure time